GWP.L Regulatory News (GWP)

GWP.L Information

There is currently no data for GWP

REMOVE ADS

Director/PDMR Shareholding

18 Jul 2008 16:38

RNS Number : 4435Z

GW Pharmaceuticals PLC

18 July 2008

GW Pharmaceuticals plc

("GW" or "the Company")

SCHEDULE 11

NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

The company was notified on 17th July 2008 that two connected persons of Dr Geoffrey Guy, a Director of the Company, each gifted 52,000 ordinary shares of 0.1p for nil consideration to a family member. The total number of shares gifted of 104,000 represents 0.09% of the issued share capital.

Following this notification Dr Guy and his connected parties have a beneficial Interest in 21,290,663 ordinary shares, amounting to 17.6% of the shares in issue.

Enquiries:

GW Pharmaceuticals plc	01980 557000
Adam George, Company Secretary

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSILFFEDIITLIT

Date		Source	Headline
25th Nov 2009	7:02 am	RNS	Patient Recruitment Completed for Sativex Study
25th Nov 2009	7:00 am	RNS	Final Results
23rd Nov 2009	7:00 am	RNS	Positive Sativex Results in Cancer Pain
4th Nov 2009	12:15 pm	RNS	Notice of Results
30th Oct 2009	4:43 pm	RNS	Blocklisting Interim Review
30th Oct 2009	3:41 pm	RNS	Total Voting Rights
17th Sep 2009	4:40 pm	RNS	Second Price Monitoring Extn
17th Sep 2009	4:35 pm	RNS	Price Monitoring Extension
17th Sep 2009	7:00 am	RNS	Update on cannabinoid pipeline
14th Sep 2009	7:00 am	RNS	Results from two clinical studies of Savitex(R)
10th Sep 2009	7:00 am	RNS	Rodman and Renshaw Conference
18th Aug 2009	4:23 pm	RNS	Holding(s) in Company
18th Aug 2009	4:18 pm	RNS	Total Voting Rights
6th Aug 2009	7:00 am	RNS	Re Agreement
28th Jul 2009	11:10 am	RNS	Director/PDMR Shareholding
16th Jul 2009	7:00 am	RNS	Manufacturing Licence Received for Sativex
26th Jun 2009	8:41 am	RNS	Director/PDMR Shareholding
24th Jun 2009	9:19 am	RNS	Director/PDMR Shareholding
16th Jun 2009	7:00 am	RNS	GW Expands Cannabinoid Research
15th Jun 2009	5:46 pm	RNS	Director/PDMR Shareholding
2nd Jun 2009	7:00 am	RNS	Holding(s) in Company
1st Jun 2009	4:12 pm	RNS	Notification of Interests of Directors
21st May 2009	4:00 pm	RNS	Director/PDMR Shareholding
20th May 2009	7:01 am	RNS	GW Files Sativex? Regulatory Submission
20th May 2009	7:00 am	RNS	Interim Results
20th Apr 2009	3:20 pm	RNS	Notice of Results
1st Apr 2009	7:00 am	RNS	?8m Milestone Payment from Almirall
31st Mar 2009	7:00 am	RNS	Blocklisting Interim Review
31st Mar 2009	7:00 am	RNS	Total Voting Rights
30th Mar 2009	10:11 am	RNS	Director/PDMR Shareholding
27th Mar 2009	4:51 pm	RNS	Director/PDMR Shareholding
13th Mar 2009	9:34 am	RNS	Notification of Interests of Directors
11th Mar 2009	1:12 pm	RNS	Positive Outcome of Sativex Phase III MS Study
2nd Mar 2009	5:38 pm	RNS	Director/PDMR Shareholding
24th Feb 2009	7:00 am	RNS	Clinical Trial Update
16th Jan 2009	5:27 pm	RNS	Director/PDMR Shareholding
14th Jan 2009	2:05 pm	RNS	Result of AGM
2nd Dec 2008	5:50 pm	RNS	Director/PDMR Shareholding
18th Nov 2008	7:00 am	RNS	Final Results
24th Oct 2008	4:47 pm	RNS	Second Price Monitoring Extn
24th Oct 2008	4:37 pm	RNS	Price Monitoring Extension
22nd Oct 2008	11:00 am	RNS	Notice of Results
10th Oct 2008	4:42 pm	RNS	Price Monitoring Extension
1st Oct 2008	7:00 am	RNS	Trial Completes Recruitment
8th Sep 2008	7:00 am	RNS	Research Update
18th Jul 2008	4:38 pm	RNS	Director/PDMR Shareholding
24th Jun 2008	3:36 pm	RNS	Blocklisting Interim Review
24th Jun 2008	3:32 pm	RNS	Blocklisting Interim Review
24th Jun 2008	3:27 pm	RNS	Blocklisting Interim Review
24th Jun 2008	3:22 pm	RNS	Blocklisting Interim Review

Latest Share Chat

GWP.L Regulatory News (GWP)

Director/PDMR Shareholding

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending